NDC 0032-0045
Creon 3000 [USP'U] / 9500 [USP'U] / 15000 [USP'U] capsule, delayed release
On the label: AbbVie Inc..
Where it's made
This label doesn't name the factory that makes the drug. Companies don't have to print it on the label. The maker's name is often on the stock bottle your pharmacy used; you can ask the pharmacist. See the plants AbbVie Inc. names for other drugs.
Recalls
- Mar 15, 2021 · Class II · Cardinal Health Inc.
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Lots: 1139494 - Sep 15, 2014 · Class II · AbbVie Inc
Presence of Foreign Tablets/Capsules; Presence of co-mingled LipaCreon 13000.
Lots: Lot #: 1020156; Expiry: 3/31/2016
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Pancrelipase Amylase and Pancrelipase Lipase and Pancrelipase Protease: every company that makes it
- Form
- capsule, delayed release, oral
- Strength
- 3000 [USP'U] / 9500 [USP'U] / 15000 [USP'U]
- Approval
- BLA BLA020725
- On the market since
- Oct 12, 2023
- Package NDCs
0032-0045-300032-0045-70- Official label
- DailyMed (National Library of Medicine), updated Feb 28, 2024
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?